Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | VP, CAO & Controller | August 01, 2023 | August 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date August 01, 2023 · Filed August 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,144.3436 |
Reported balance
After 2023-08-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-08-01 · Grant · Acquired 5,425 · Balance 17,144.3436 F1: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on August 1, 2026. F2: Includes directly owned shares, stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on August 1, 2026.
F2: Includes directly owned shares, stock units and dividend equivalent units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2023 Filed Aug 3, 2023 16:51 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 5,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044469 · doc4.xml · nonDerivative · entry 1 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,144.3436 F1 · shares: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on August 1, 2026. F2 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 20:47 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 487 | $36.12 | $17,590.44 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 3 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,660.8853 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 4,813 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · derivative · entry 5 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,813 Underlying: Common Stock · 4,813 shares Expires 2033-03-01 F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 4,882 | $0.00 Strike: $34.84 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · derivative · entry 4 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,882 Underlying: Common Stock · 4,882 shares Expires 2033-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 2 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,147.8853 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:47 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 564 | $34.84 | $19,649.76 |
DisclosureSEC source: 0001209191-23-016079 · doc4.xml · nonDerivative · entry 1 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,995.8853 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2023 Filed Mar 10, 2023 13:53 UTC Amendment | Chemours Co CC · Entity 4420 | GrantPerformance Stock Option (Right to Buy) · Derivative | 5,010 | $0.00 Strike: $38.32 | $0.00 |
DisclosureSEC source: 0001209191-23-017762 · doc4a.xml · derivative · entry 1 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,010 Underlying: Common Stock · 5,010 shares Expires 2033-03-01 F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person. F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 18:02 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 467 | $27.01 | $12,613.67 |
DisclosureSEC source: 0001627223-22-000022 · primary_doc.xml · nonDerivative · entry 3 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,404 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:02 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 12,133 | $0.00 Strike: $25.98 | $0.00 |
DisclosureSEC source: 0001627223-22-000022 · primary_doc.xml · derivative · entry 4 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,133 Underlying: Common Stock · 12,133 shares Expires 2032-03-01 F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2023. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:02 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 1,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-22-000022 · primary_doc.xml · nonDerivative · entry 2 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,871.514 F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 18:02 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 526 | $25.98 | $13,665.48 |
DisclosureSEC source: 0001627223-22-000022 · primary_doc.xml · nonDerivative · entry 1 Wisel Camela · CIK 0001886003 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,717.514 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.